💥 Role of Stents in Dialysis Vascular Access - Tweetorial

⚡️Indications for Stent Use

⚡️Recent Clinical Trials of Stents in Dialysis Vascular Access

⚡️Complications associated with Stent Use

1/
@ASDINNews
#VascularAccessPearls

⚡️Arterio-venous (AV) Access
causes significant morbidity & mortality in patients on hemodialysis

⚡️Most AV access associated complications are due to vascular stenosis👇🏽
2/
⚡️Vascular Access care has evolved over the past 60 years:

-Scribner’s Shunt in 1960 ➡️
-Brescia-Cimino AVF in 1966 ➡️
-1st Balloon Angioplasty in 1981 ➡️
-1st Bare Metal Stent in 1988 ➡️
-1st Covered Stent in 1996 ➡️
-DCB use in 2012
3/
⚡️Despite these innovations, AV access stenosis remains a big problem

-Percutaneous Balloon Angioplasty (PTA) remains the 1st line therapy for stenosis but it is NOT very effective

-AVF patency after PTA is only 50% at 6-months & it is worse for AVGs👇🏽
4/
⚡️Neointimal Hyperplasia (NIH) causes vascular stenosis & it is due to:

-Hemodynamic stress
-Surgical trauma
-Cannulation needle trauma
-AVG

‼️But balloon angioplasty, the treatment for stenosis, can itself induce NIH & cause restenosis👇🏽
5/
⚡️Therefore, Endovascular Stents have been used to treat the vascular stenosis

⚡️What are Endovascular Stents?
They are scaffolds that provide mechanical endoluminal support to the vessel wall to maintain patency
6/
⚡️Types of Stents:

-1st generation stents were Bare-Metal Stents made of stainless steel

-Next generation of metal stents were Nitinol Stents made of nickel-titanium alloy

- Covered-Stents (Stent-Grafts) are Nitinol stents covered w/ ePTFE or Dacron
7/
⚡️Bare Metal Stents & Nitinol Stents have problems because the tissue in-growth through the bare metal causes restenosis

⚡️Covered Stents (Stent-Grafts) theoretically form a barrier, & prevent tissue in-growth through the stent & cause less restenosis👇🏽
8/
⚡️Recent clinical trials have tested the efficacy of Stent-Grafts for AV access stenosis
⚡️But before we get to the trials, let’s discuss the basic indications for Stent use:

☄️Rupture of the vessel
☄️Recoil (Residual stenosis)
☄️Restenosis
9/
⚡️Rupture of the vessel can occur during angioplasty of a severely stenotic lesion

⚡️In most cases, extravasation can be controlled w/ manual compression or balloon tamponade but if bleeding persists then stents can be used to control the bleeding👇🏽
10/
⚡️Another indication for Stent use is Recoil

⚡️Recoil is defined as residual stenosis of > 30% following angioplasty & is thought to occur due to elastic recoil of the vessel wall

⚡️Recoil is associated w/ poor AV access survival👇🏽
11/
⚡️Restenosis is the most common indication for stent use👇🏽

⚡️AVG patency post-angioplasty is very poor👇🏽

⚡️Most common site for AVG stenosis is at the graft-vein anastomosis, therefore recent clinical trials have tested the Stent-grafts at this site👇🏽
12/
⚡️Stent-Graft (SG)Trials in Dialysis Vascular Access

☄️Flair PIVOTAL Trial: Flair SG vs. PTA for AVG
☄️REVISE Trial: Viabahn SG vs PTA for AVG

⚡️Both trials showed better 6-month patency with SG use compared to PTA for graft-vein anastomosis stenosis👇🏽
13/
⚡️Stent-Grafts (SG) have also been tested for In-stent restenosis

☄️RESCUE Trial: Fluency SG vs PTA for In-stent restenosis in both AVF & AVG

⚡️RESCUE Trial showed better 6-month patency with SG compared to PTA👇🏽
14/
⚡️Summary of Stent Trials in Dialysis Vascular Access👇🏽
15/
⚡️Based on this data, KDOQI 2019 guidelines recommend Stent-Graft use for:

☄️Recurrent graft-vein anastomosis stenosis in AVG

☄️In-stent restenosis in AVF & AVG👇🏽

16/
⚡️Cost analysis of Stent-Grafts (SG) show that even though the initial cost of the SG is higher than the cost of balloon angioplasty, the overall cost was similar in the 2 groups at 24-months because the re-intervention rate was lower in the SG group👇🏽
17/
⚡️Complications associated with Stent use:

☄️Stent Migration
☄️Stent Fracture
☄️Stent Strut Protrusion
☄️Jailing of the veins
☄️Infection
18/
⚡️Stent Migration can cause downstream vein occlusion/stenosis & can impact future AV access options

⚡️Stent fracture & protrusion can occur due to repeated cannulation thru the stent👇🏽

⚡️Stent fracture can occur if stent is placed across a joint👇🏽
19/
⚡️Jailing of the Veins is a complication of stent placement & this can impact future AV access options

⚡️Hence, the operator must be very careful during stent deployment in order to avoid this complication👇🏽
20/
⚡️Stent associated infection is a serious complication & may require AV access excision

⚡️Stent associated AV access infections are more common when the stents are placed in the Pseudo-aneurysms 👇🏽
21/
⚡️Stent placement must be avoided in pseudo-aneurysms & in the cannulation zone due to high risk of infection & risk of stent fracture from needle trauma
⚡️KDOQI Guidelines state that stent placement for pseudo-aneurysm only be used as a ‘last resort’👇🏽
22/
💥Summary

⚡️Stent-Grafts are a viable therapeutic option for AV access stenosis but it’s use must be guided by scientific evidence

⚡️Balloon angioplasty remains the 1st line therapy for the majority of the AV access stenotic lesions

End/

More from Health

Before we get too far into 2021, I thought I’d write a thread recapping some of the research that came out of my lab in 2020. Most of this work was led by my talented team of graduate students, Kerrianne Morrison, @kmdebrabander, and @DesiRJones.

Back in January, a news story was published about Kerrianne’s study showing improved social interaction outcomes for autistic adults when paired with another autistic partner.

A detailed thread about the study and a link to the paper can be found here (feel free to DM me your email address if you’d like a copy of the full paper for this study or any of our studies):


Another paper published early in 2020 (it appeared a few months earlier online) showed that traditional standalone tasks of social cognition are less predictive of functional and social skills among autistic adults than commonly assumed in autism research.


Next, @kmdebrabander led and published an innovative study about how well autistic and non-autistic adults can predict their own cognitive and social cognitive performance.

You May Also Like

I’m torn on how to approach the idea of luck. I’m the first to admit that I am one of the luckiest people on the planet. To be born into a prosperous American family in 1960 with smart parents is to start life on third base. The odds against my very existence are astronomical.


I’ve always felt that the luckiest people I know had a talent for recognizing circumstances, not of their own making, that were conducive to a favorable outcome and their ability to quickly take advantage of them.

In other words, dumb luck was just that, it required no awareness on the person’s part, whereas “smart” luck involved awareness followed by action before the circumstances changed.

So, was I “lucky” to be born when I was—nothing I had any control over—and that I came of age just as huge databases and computers were advancing to the point where I could use those tools to write “What Works on Wall Street?” Absolutely.

Was I lucky to start my stock market investments near the peak of interest rates which allowed me to spend the majority of my adult life in a falling rate environment? Yup.
1/12

RT-PCR corona (test) scam

Symptomatic people are tested for one and only one respiratory virus. This means that other acute respiratory infections are reclassified as


2/12

It is tested exquisitely with a hypersensitive non-specific RT-PCR test / Ct >35 (>30 is nonsense, >35 is madness), without considering Ct and clinical context. This means that more acute respiratory infections are reclassified as


3/12

The Drosten RT-PCR test is fabricated in a way that each country and laboratory perform it differently at too high Ct and that the high rate of false positives increases massively due to cross-reaction with other (corona) viruses in the "flu


4/12

Even asymptomatic, previously called healthy, people are tested (en masse) in this way, although there is no epidemiologically relevant asymptomatic transmission. This means that even healthy people are declared as COVID


5/12

Deaths within 28 days after a positive RT-PCR test from whatever cause are designated as deaths WITH COVID. This means that other causes of death are reclassified as